Persistent symptoms deserve more than a shrug When nausea, fatigue, dizziness, or post-injection weakness do not follow the expected pattern, our Micronutrient Testing service can help connect symptoms with nutrient status, medication effects, and baseline lab trends before another injection is added
AOD 9604 and Lipolysis Research Early investigations into the effects of AOD 9604 peptide involved studies conducted on obese mice over a period of 14 days
Some participants lost even more
GLP-1 receptor agonism promotes insulin secretion in a glucose-dependent manner, reduces appetite, and slows gastric emptying
Scientific Insights According to a study published in the Journal of Nutrition , individuals with higher B12 levels had a lower risk of obesity
Stacking & comparisons AOD-9604 is the fat-metabolism specialist of the GH family: it copies only the C-terminal lipolytic domain of growth hormone, so it stimulates fat breakdown without binding the GH receptor or raising IGF-1